Joel Linden

Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation

Courtney M. Lappas, Yuan‐Ji Day, Melissa A. Marshall et al. · The Journal of Experimental Medicine · 2006 · 288 citations · Full text

Canine Mast Cell Adenosine Receptors: Cloning and Expression of the A3 Receptor and Evidence that Degranulation Is Mediated by the A2B Receptor

John A. Auchampach, Xiaowei Jin, Tina C. Wan et al. · Molecular Pharmacology · 1997 · 200 citations

NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-γ and CXCR3 chemokines

Kori Wallace, Melissa A. Marshall, Susan I. Ramos et al. · Blood · 2009 · 153 citations · Full text

Leukocyte compartments in the mouse lung: Distinguishing between marginated, interstitial, and alveolar cells in response to injury

Kathryn E. Barletta, R. Cagnina, Kori Wallace et al. · Journal of Immunological Methods · 2011 · 107 citations

Inflammation, Lung Deposition, Lung Inflammation +13

Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A_2Areceptor activation

Steven H. Platts, Joel Linden, Brian R. Duling · American Journal of Physiology-Heart and Circulatory Physiology · 2003 · 78 citations

Molecular Pharmacology, Molecular Physiology, Signal Transduction +15